The Hollywood sign and … Erewhon? How the luxury grocery store became an L.A. tourist destination

The UK government has launched a national inquiry into maternity services, specifically focusing on the hospitals with the worst performance records in England. The investigation is expected to wrap up by the end of the year, likely leading to recommendations for improvement—or possibly even systemic changes.

Editor’s Note: Maternity care is one of those things you don’t think about until something goes wrong—and when it does, the consequences can be devastating. This inquiry suggests there’s been enough concern over failing services to warrant a closer look. For expectant parents, it’s a sign that problems are being taken seriously, but also a reminder that not all hospitals are delivering the same standard of care. The findings could push for overdue reforms in how maternity services are run.

Hitting that mid-afternoon wall where your energy crashes and focus fades? You're not alone. A women's health dietitian breaks down simple, science-backed tweaks to keep you energized—like smarter snack choices, the surprising power of daylight, and why that 3 PM coffee might backfire.

Editor’s Note: Let’s face it—afternoon slumps wreck productivity and mood for millions. This isn’t just about quick fixes; it’s about small, sustainable habits that actually work (and might save you from that fourth cup of coffee). For anyone juggling work, life, or just staying awake past 2 PM, these tips are gold.

Big health insurance companies are finally acknowledging a frustrating issue many patients face: lengthy, bureaucratic coverage reviews that often delay or deny necessary care. They’re pledging to streamline the process, though details on how—and how much—remain unclear.

Editor’s Note: If you’ve ever fought with your insurer over pre-approvals or waited weeks for a green light on treatment, this might sound like progress. But promises are easy—real change depends on whether insurers actually follow through. For patients stuck in limbo, this could mean fewer headaches… or just another empty corporate pledge.

Eli Lilly, the pharmaceutical giant behind Ozempic and Wegovy, is making waves with a new weight loss pill that’s showing strong results in trials—up to 23% weight loss for some participants. While the current buzz is around injectable treatments, this oral option could be a game-changer for people who dislike needles. Dr. Roshini Raj from NYU Langone Health breaks down how it stacks up against existing drugs and when it might actually hit pharmacy shelves.

Editor’s Note: Weight loss drugs are having a moment, and this pill could be the next big thing. If approved, it would offer a more convenient alternative to injections, potentially expanding access for millions. With obesity rates climbing, new treatments like this aren’t just about vanity—they’re a serious step toward tackling a major public health issue.

This piece dives into the latest chatter in the health care investment scene, spotlighting players like Riverstone Holdings and CSL’s vaccine division. Think of it as a quick pulse-check on where money’s flowing and which companies are making waves—whether through deals, innovations, or market moves.

Editor’s Note: For anyone tracking the business side of health care—investors, professionals, or just the financially curious—this roundup offers a snapshot of who’s up, who’s interesting, and where the sector might be headed next. It’s not breaking news, but it’s the kind of insider-ish talk that helps connect dots in a fast-moving industry.